Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stem Cell Reserve
AddedFeb 16, 2024
UpdatedJun 18, 2026
Stem Cell Reserve

Stem Cell Reserve

SCR revolutionizes banking industry with a hybrid biobanking model, offering diverse, FDA-approved stem cell storage and regenerative solutions in Houston.

HQ
Houston, TX, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Stem Cell Reserve, founded by Raymond Mouzannar, PhD, is dedicated to revolutionizing the banking industry through its innovative hybrid biobanking model. The company offers a range of FDA-approved stem cell storage and regenerative solutions, focusing on both private and public banking products. Utilizing proprietary techniques, Stem Cell Reserve extracts all stem cells and a supportive bioscaffold from umbilical cord tissue, aiming to develop superior regenerative therapies. Their mission is to harness the power of the umbilical cord to improve lives globally.

Notable figures affiliated with Stem Cell Reserve include its founder, Raymond Mouzannar, a seasoned stem cell scientist and epigeneticist. The company has achieved significant milestones in the field of regenerative medicine by introducing new stem cell products that challenge traditional cord blood banking models. With its pioneering approach and adherence to stringent regulatory standards, Stem Cell Reserve has made a substantial impact on the industry, positioning itself as a leader in advancing stem cell science and improving patient outcomes.

Stem Cell Reserve - Similar Companies

StemSave logo

StemSave

stemsave.com

Celltex Therapeutics logo

Celltex Therapeutics

celltexbank.com

Personalized Stem Cells logo

Personalized Stem Cells

Stemcyte logo

Stemcyte

stemcyte.com

American CryoStem logo

American CryoStem

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

StemBioSys logo

StemBioSys

stembiosys.com

Stemgenics logo

Stemgenics

stemgenics.com

Next Healthcare logo

Next Healthcare

AdiCyte logo

AdiCyte

MyCordBank.com logo

MyCordBank.com

mycordbank.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

MitoStem logo

MitoStem

LaCell logo

LaCell

Ossium Health logo

Ossium Health

ossiumhealth.com

Stem Cell Reserve - Quick Facts

Who are Stem Cell Reserve's competitors?

Companies similar to Stem Cell Reserve include StemSave, Celltex Therapeutics, Personalized Stem Cells and Stemcyte.

When was Stem Cell Reserve founded?

Stem Cell Reserve was founded in 2009.

Where is Stem Cell Reserve's headquarters located?

Stem Cell Reserve's headquarters is located in Houston, TX, US.

When was Stem Cell Reserve's last funding round?

Stem Cell Reserve's most recent funding round was for $2M (USD) in May 2017.

How much has Stem Cell Reserve raised to-date?

As of May 2, 2017, Stem Cell Reserve has raised a total of $2M (USD).

How many employees does Stem Cell Reserve have?

Stem Cell Reserve has 30 employees as of Feb 4, 2024.

Stem Cell Reserve - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Stem Cell Banking
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified